News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,271 Results
Type
Article (26045)
Company Profile (60)
Press Release (359166)
Section
Business (105874)
Career Advice (454)
Deals (17202)
Drug Delivery (50)
Drug Development (47923)
Employer Resources (47)
FDA (12384)
Job Trends (8577)
News (188352)
Policy (19590)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1756)
Accelerated approval (1)
Adcomms (8)
Allergies (68)
Alliances (27302)
ALS (52)
Alzheimer's disease (800)
Antibody-drug conjugate (ADC) (41)
Approvals (12436)
Artificial intelligence (158)
Autoimmune disease (8)
Automation (4)
Bankruptcy (144)
Best Places to Work (7025)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (39)
Bladder cancer (45)
Brain cancer (15)
Breast cancer (174)
Cancer (1292)
Cardiovascular disease (110)
Career advice (410)
Career pathing (13)
CAR-T (64)
Cell therapy (190)
Cervical cancer (13)
Clinical research (40588)
Collaboration (420)
Compensation (112)
Complete response letters (9)
COVID-19 (1492)
CRISPR (11)
C-suite (122)
Cystic fibrosis (42)
Data (1377)
Decentralized trials (2)
Denatured (16)
Depression (29)
Diabetes (161)
Diagnostics (3659)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (50)
Drug pricing (53)
Drug shortages (21)
Duchenne muscular dystrophy (47)
Earnings (37407)
Editorial (18)
Employer branding (6)
Employer resources (44)
Events (52106)
Executive appointments (405)
FDA (13267)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (378)
Gene editing (33)
Generative AI (10)
Gene therapy (120)
GLP-1 (385)
Government (3037)
Grass and pollen (3)
Guidances (35)
Healthcare (12346)
Huntington's disease (9)
IgA nephropathy (13)
Immunology and inflammation (37)
Indications (18)
Infectious disease (1557)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (23)
Intellectual property (47)
Interviews (41)
IPO (7184)
IRA (19)
Job creations (1849)
Job search strategy (381)
Kidney cancer (7)
Labor market (8)
Layoffs (166)
Leadership (3)
Legal (3650)
Liver cancer (53)
Lung cancer (218)
Lymphoma (87)
Machine learning (2)
Management (17)
Manufacturing (94)
MASH (43)
Medical device (12889)
Medtech (12892)
Mergers & acquisitions (10286)
Metabolic disorders (397)
Multiple sclerosis (47)
NASH (11)
Neurodegenerative disease (43)
Neuropsychiatric disorders (9)
Neuroscience (1095)
NextGen: Class of 2025 (3959)
Non-profit (2850)
Northern California (1239)
Now hiring (16)
Obesity (206)
Opinion (70)
Ovarian cancer (51)
Pain (58)
Pancreatic cancer (49)
Parkinson's disease (80)
Partnered (10)
Patents (101)
Patient recruitment (70)
Peanut (37)
People (34899)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11662)
Phase II (17567)
Phase III (14424)
Pipeline (600)
Podcasts (24)
Policy (49)
Postmarket research (1671)
Preclinical (3652)
Press Release (18)
Prostate cancer (67)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (171)
Real estate (2863)
Recruiting (16)
Regulatory (14270)
Reports (16)
Research institute (1618)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (18)
Schizophrenia (46)
Series A (60)
Series B (43)
Service/supplier (3)
Sickle cell disease (20)
Southern California (1087)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (12)
Startups (2129)
Stomach cancer (8)
Supply chain (35)
The Weekly (8)
United States (11909)
Vaccines (338)
Venture capitalists (13)
Webinars (7)
Weight loss (134)
Women's health (19)
Worklife (4)
Date
Today (78)
Last 7 days (423)
Last 30 days (1556)
Last 365 days (19149)
2025 (4543)
2024 (20029)
2023 (22983)
2022 (31206)
2021 (33445)
2020 (32622)
2019 (28776)
2018 (22128)
2017 (19260)
2016 (18429)
2015 (21576)
2014 (16316)
2013 (13423)
2012 (14572)
2011 (14814)
2010 (13305)
Location
Africa (355)
Alabama (21)
Alaska (2)
Arizona (117)
Arkansas (10)
Asia (24674)
Australia (3915)
California (2802)
Canada (1139)
China (339)
Colorado (154)
Connecticut (161)
Delaware (101)
Europe (48295)
Florida (499)
Georgia (125)
Idaho (34)
Illinois (337)
India (13)
Indiana (215)
Iowa (2)
Japan (104)
Kansas (70)
Kentucky (12)
Louisiana (5)
Maine (27)
Maryland (597)
Massachusetts (1974)
Michigan (124)
Minnesota (271)
Mississippi (2)
Missouri (51)
Montana (18)
Nebraska (18)
Nevada (28)
New Hampshire (60)
New Jersey (1031)
New Mexico (10)
New York (869)
North Carolina (540)
North Dakota (3)
Northern California (1239)
Ohio (123)
Oklahoma (3)
Oregon (23)
Pennsylvania (758)
Puerto Rico (7)
Rhode Island (20)
South America (521)
South Carolina (16)
Southern California (1087)
Tennessee (70)
Texas (490)
Utah (102)
Virginia (91)
Washington D.C. (36)
Washington State (212)
West Virginia (3)
Wisconsin (37)
385,271 Results for "companion medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
March 31, 2025
·
2 min read
Press Releases
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
March 10, 2025
·
3 min read
Press Releases
BostonGene Contributes to Friends of Cancer Research White Paper Introducing a Novel Process for Companion Diagnostics for Rare Biomarkers and Indications
February 4, 2025
·
2 min read
Press Releases
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
February 2, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
December 10, 2024
·
2 min read
Press Releases
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
October 23, 2024
·
5 min read
Press Releases
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
December 18, 2024
·
3 min read
FDA
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for AKEEGA® (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen Biotech, Inc.
July 1, 2024
·
6 min read
Press Releases
Caris Life Sciences Receives FDA Approval for MI Cancer Seek™ as a Companion Diagnostic (CDx) Test
November 6, 2024
·
5 min read
1 of 38,528
Next
